JH Karnes, RM Cooper-DeHoff - Expert Review of Cardiovascular Therapy, 2009 - ingentaconnect.com For almost as long as thiazide diuretics and b-blockers have been available,
there has been concern over their metabolic effects. While in
somecasestheseconcernshaveleadtopreferential prescribing of other ... Related articles - All 4 versions
TD Giles - The Journal of Clinical Hypertension, 2009 - interscience.wiley.com Cardiovascular disease accounts for the majority of deaths in patients with type
2 diabetes mellitus. Lifestyle interventions aimed at weight loss and increased
physical activity and therapy with antidiabetic drugs have proven effective ... Related articles - All 3 versions
RM Cooper-DeHoff - Expert Rev. Cardiovasc. Ther., 2008 - expert-reviews.com Despite these insightful recommendations, benzothiadiazine derivatives (most
often hydrochlorothiazide [HCTZ]) are the first-line recommended therapy for
hypertension, regardless of glycemic status [2]. Epidemiologic data, as ... Cited by 1 - Related articles - All 4 versions
GP Jong, MH Chang, L Tien, SY Li, YS Liou, … - Cardiovascular Therapeutics, 2009 - interscience.wiley.com Antihypertensive drugs have been linked to new-onset diabetes (NOD); however,
data on the effect of these drugs on the development of NOD in hypertensive
patients has not been well determined. We aimed to investigate the ... Related articles - All 2 versions
JN Basile, 2009 - pubmedcentral.nih.gov Type 2 diabetes mellitus is a worldwide epidemic with considerable health and
economic consequences. Diabetes is an important risk factor for cardiovascular
disease, which is the leading cause of death in diabetic patients, and ... Related articles - All 5 versions